Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) FCF Margin (2016 - 2025)

Historic FCF Margin for Marimed (MRMD) over the last 14 years, with Q3 2025 value amounting to 5.19%.

  • Marimed's FCF Margin rose 95400.0% to 5.19% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.05%, marking a year-over-year increase of 47600.0%. This contributed to the annual value of 3.28% for FY2024, which is 49500.0% up from last year.
  • According to the latest figures from Q3 2025, Marimed's FCF Margin is 5.19%, which was up 95400.0% from 0.03% recorded in Q2 2025.
  • Over the past 5 years, Marimed's FCF Margin peaked at 18.06% during Q1 2021, and registered a low of 30.62% during Q2 2022.
  • For the 5-year period, Marimed's FCF Margin averaged around 0.87%, with its median value being 0.03% (2025).
  • Its FCF Margin has fluctuated over the past 5 years, first surged by 417700bps in 2021, then plummeted by -464800bps in 2022.
  • Over the past 5 years, Marimed's FCF Margin (Quarter) stood at 14.12% in 2021, then tumbled by -108bps to 1.17% in 2022, then crashed by -373bps to 5.52% in 2023, then surged by 32bps to 3.75% in 2024, then soared by 238bps to 5.19% in 2025.
  • Its last three reported values are 5.19% in Q3 2025, 0.03% for Q2 2025, and 2.71% during Q1 2025.